WO2002008421A1 - Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide - Google Patents
Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide Download PDFInfo
- Publication number
- WO2002008421A1 WO2002008421A1 PCT/CN2001/001078 CN0101078W WO0208421A1 WO 2002008421 A1 WO2002008421 A1 WO 2002008421A1 CN 0101078 W CN0101078 W CN 0101078W WO 0208421 A1 WO0208421 A1 WO 0208421A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- polynucleotide encoding
- necrosis factor
- factor receptor
- tumor necrosis
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 title abstract 3
- 102000057041 human TNF Human genes 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 102000005962 receptors Human genes 0.000 title abstract 3
- 108020003175 receptors Proteins 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention concerne un nouveau polypeptide, un récepteur humain 21.45 du facteur de la nécrose tumorale, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de diverses tumeurs et de maladies dues à des inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la récepteur humain 21.45 du facteur de la nécrose tumorale.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002210318A AU2002210318A1 (en) | 2000-06-30 | 2001-06-29 | A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00116922.X | 2000-06-30 | ||
| CN 00116922 CN1331208A (zh) | 2000-06-30 | 2000-06-30 | 一种新的多肽——人肿瘤坏死因子受体21.45和编码这种多肽的多核苷酸 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002008421A1 true WO2002008421A1 (fr) | 2002-01-31 |
Family
ID=4586321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/001078 WO2002008421A1 (fr) | 2000-06-30 | 2001-06-29 | Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1331208A (fr) |
| AU (1) | AU2002210318A1 (fr) |
| WO (1) | WO2002008421A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3346995B1 (fr) | 2015-11-09 | 2019-08-28 | Gilead Sciences, Inc. | Compositions thérapeutiques pour le traitement du virus de l'immunodéficience humaine |
-
2000
- 2000-06-30 CN CN 00116922 patent/CN1331208A/zh active Pending
-
2001
- 2001-06-29 WO PCT/CN2001/001078 patent/WO2002008421A1/fr active Application Filing
- 2001-06-29 AU AU2002210318A patent/AU2002210318A1/en not_active Abandoned
Non-Patent Citations (5)
| Title |
|---|
| DATABASE GENBANK [online] 12 December 1999 (1999-12-12), accession no. EMBL Database accession no. AL023577 * |
| DATABASE GENBANK [online] 12 December 1999 (1999-12-12), accession no. EMBL Database accession no. AL031588 * |
| DATABASE GENBANK [online] 14 December 1999 (1999-12-14), accession no. EMBL Database accession no. AL022325 * |
| DATABASE GENBANK [online] 17 November 1994 (1994-11-17), Database accession no. U14571 * |
| DATABASE GENBANK [online] 29 January 1998 (1998-01-29), Database accession no. AC002418 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3346995B1 (fr) | 2015-11-09 | 2019-08-28 | Gilead Sciences, Inc. | Compositions thérapeutiques pour le traitement du virus de l'immunodéficience humaine |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002210318A1 (en) | 2002-02-05 |
| CN1331208A (zh) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002008421A1 (fr) | Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide | |
| WO2002000822A3 (fr) | Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide | |
| WO2001096526A3 (fr) | Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide | |
| WO2002000826A3 (fr) | Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2002000824A3 (fr) | Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide | |
| WO2001075054A3 (fr) | Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide | |
| WO2001075053A3 (fr) | Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001079439A3 (fr) | Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide | |
| WO2001075023A3 (fr) | Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001081534A3 (fr) | Nouveau polypeptide, oxydoreductase 2fe-2s humaine 12, et polynucleotide codant pour ce polypeptide | |
| WO2001075016A3 (fr) | Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide | |
| WO2001075020A3 (fr) | Nouveau polypeptide, neuroproteine humaine y 11, et polynucleotide codant pour ce polypeptide | |
| WO2001075062A3 (fr) | Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075056A3 (fr) | Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide | |
| WO2001096524A3 (fr) | Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide | |
| WO2001075018A3 (fr) | Nouveau polypeptide, facteur humain de regulation de la transcription 31, et polynucleotide codant pour ce polypeptide | |
| WO2001075011A3 (fr) | Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide | |
| WO2001075048A3 (fr) | Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide | |
| WO2001075029A3 (fr) | Nouveau polypeptide, facteur humain 11 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001075024A3 (fr) | Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001075043A3 (fr) | Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide | |
| WO2001083685A3 (fr) | Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide | |
| WO2002008422A1 (fr) | Nouveau polypeptide, proteine du myotube humaine 10.56, et polynucleotide codant ce polypeptide | |
| WO2001079427A3 (fr) | Nouveau polypeptide, canal ionique humain 9 pour le chlore, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |